CoA Therapeutics
Phase 1CoA Therapeutics is targeting Coenzyme-A for patients with PKAN, organic acidurias and other diseases of CoA sequestration
Founded
2018
Focus
Small Molecules
About
CoA Therapeutics is targeting Coenzyme-A for patients with PKAN, organic acidurias and other diseases of CoA sequestration
Funding History
2Total raised: $105M
Series B$75MCormorant Asset ManagementJul 15, 2021
Series A$30MNovo HoldingsJan 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile